SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000903954-03-000061
Filing Date
2003-12-22
Accepted
2003-12-22 13:38:26
Documents
1

Document Format Files

Seq Description Document Type Size
1 sc13g-lynx122203.txt SC 13G 10707
  Complete submission text file 0000903954-03-000061.txt   12917
Mailing Address CREDIT SUISSE ASSET MANAGEMENT, LLC 466 LEXINGTON AVENUE 12TH FLOOR NEW YORK NY 10017
Business Address 466 LEXINGTON AVENUE 12TH FLOOR NEW YORK NY 10017 2128753500
CREDIT SUISSE ASSET MANAGEMENT LLC/NY (Filed by) CIK: 0000903954 (see all company filings)

IRS No.: 133580284 | State of Incorp.: DE | Fiscal Year End: 1231

Mailing Address 3832 BAY CENTER PLACE HAYWARD CA 94545
Business Address 3832 BAY CENTER PL HAYWARD CA 94545 5106709300
LYNX THERAPEUTICS INC (Subject) CIK: 0000913275 (see all company filings)

IRS No.: 943161073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-45862 | Film No.: 031067200
SIC: 2833 Medicinal Chemicals & Botanical Products